Resmed Inc
NYSE:RMD

Watchlist Manager
Resmed Inc Logo
Resmed Inc
NYSE:RMD
Watchlist
Price: 243.61 USD -0.27%
Market Cap: 35.8B USD
Have any thoughts about
Resmed Inc?
Write Note

Resmed Inc
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Resmed Inc
Cost of Revenue Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Resmed Inc
NYSE:RMD
Cost of Revenue
-$2B
CAGR 3-Years
-12%
CAGR 5-Years
-12%
CAGR 10-Years
-13%
Becton Dickinson and Co
NYSE:BDX
Cost of Revenue
-$10.8B
CAGR 3-Years
-3%
CAGR 5-Years
-4%
CAGR 10-Years
-10%
Boston Scientific Corp
NYSE:BSX
Cost of Revenue
-$4.9B
CAGR 3-Years
-9%
CAGR 5-Years
-10%
CAGR 10-Years
-8%
Stryker Corp
NYSE:SYK
Cost of Revenue
-$7.9B
CAGR 3-Years
-11%
CAGR 5-Years
-10%
CAGR 10-Years
-9%
Abbott Laboratories
NYSE:ABT
Cost of Revenue
-$18.3B
CAGR 3-Years
0%
CAGR 5-Years
-7%
CAGR 10-Years
-7%
Intuitive Surgical Inc
NASDAQ:ISRG
Cost of Revenue
-$2.6B
CAGR 3-Years
-15%
CAGR 5-Years
-15%
CAGR 10-Years
-14%

See Also

What is Resmed Inc's Cost of Revenue?
Cost of Revenue
-2B USD

Based on the financial report for Sep 30, 2024, Resmed Inc's Cost of Revenue amounts to -2B USD.

What is Resmed Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-13%

Over the last year, the Cost of Revenue growth was -4%. The average annual Cost of Revenue growth rates for Resmed Inc have been -12% over the past three years , -12% over the past five years , and -13% over the past ten years .

Back to Top